On Demand WebinarDigitaler Workflow bei Sofortimplantation
Dr. Stefan Scherg
April 09, 2021 | Advertorial
ZURICH, Switzerland: Dental implantology leader Nobel Biocare has expanded its portfolio of regenerative products with the launch of creos syntoprotect, a new line of dense PTFE membranes. According to the company, the expansion will allow creos—its regenerative solutions brand—to make a decisive movement towards meeting the ever-changing needs of dental professionals.
March 22, 2021 | News
LEIPZIG, Germany: Exactly six months from today, the 2021 International Dental Show (IDS) is slated to open. The 39th edition of the world’s leading dental trade fair was originally scheduled to take place from 10 to 13 March before the event organisers decided last December to postpone it to 22–25 September 2021. With clinically tested SARS-CoV-2 vaccines being rolled out across many countries, the prospects for IDS 2021 have now become a good deal rosier, leading the event organisers to declare that preparations are “going very well”.
March 04, 2021 | Business
LEIPZIG, Germany: The SARS-CoV-2 pandemic has already proved to be the greatest challenge that dental manufacturers have faced. The oral health giants Dentsply Sirona, Henry Schein and Envista Holdings all showed strong signs of recovery in their fourth-quarter results for 2020. It seems that the Straumann Group is not the only major market competitor to have seen growth in dental sales return late last year.
January 27, 2021 | Advertorial
YORBA LINDA, Calif., U.S.: Nobel Biocare is inviting dental professionals to join what it calls the Mucointegration era with the launch of its Xeal and TiUltra surfaces in the U.S. These new surfaces are applied to implants and abutments, optimizing tissue integration at every level.
December 17, 2020 | Advertorial
An award-winning clinician, researcher and director at the Brånemark Centre in Perth in Australia, Dr Graham Carmichael is a consultant prosthodontist and an adjunct clinical senior lecturer at the University of Western Australia. He has trained dentists and specialists in implant dentistry since 2006. In this interview, he discusses what he most appreciates about the Xeal abutment surface and the TiUltra implant surface and offers his opinion about their long-term potential.
November 06, 2020 | Advertorial
ZURICH, Switzerland: Nobel Biocare and DOCERAM Medical Ceramics are combining their strengths in order to offer high-quality restorative solutions which will provide ease and flexibility of use for their customers. The first achievement in this strengthened partnership is the release of the NobelProcera Zirconia Implant Bridge, which enables restorative flexibility through a simplified workflow and is produced in the high-end Nacera Pearl zirconia material.
September 17, 2020 | News
NEW YORK, U.S.: On Sept. 9 and 10, Baird Equity Research held its annual Global Healthcare Conference. Traditionally hosted in New York, the invite-only congress was conducted virtually this year owing to the ongoing pandemic. Attendees were able to engage with presentations by representatives of more than 90 of the world’s leading health care and dental companies, who were on hand to showcase their respective plans for navigating a path to profit in a post-COVID-19 landscape.
When it comes to innovations in implant dentistry, the refinement of site preparation has fallen behind the advancements of implant design. Prof. Stefan Holst, Vice President of Premium Implants at Nobel Biocare and co-author of an original research study with Stanford University on the OsseoShaper design and biological benefits, describes some of the challenges presented by conventional drilling protocols and explains how this new device has been designed to overcome these problems.
May 18, 2020 | Business
NEW YORK, U.S.: Dentistry faces an earnest struggle to adapt to what some have called the new reality. A series of investor updates from major dental companies shows us that digital tools are now more important than ever for education and in customer service environments. Some dental companies have taken extraordinary measures to sure up manufacturing and supply, and significant adverse financial impacts have been shouldered.